Independent information hub. Some product links are affiliate links — we may earn a commission. Not medical advice.

Independent research brief · Updated Aug 2026

Clascoterone hair growth, without the hype.

A topical androgen-receptor blocker just finished the largest Phase 3 programme ever run on a topical for male pattern baldness. Here is what the numbers actually say — and what you can use while you wait.

Investigational 5% solution (Breezula) 1,465 men in SCALP 1 + 2 US filing targeted early 2027
Close-up of scalp hair shafts in studio light
Not FDA-approved for hair loss · Aug 2026
1,465Men in Phase 3 SCALP trials
12 moContinued growth if treatment held
2.39×TAHC vs men who stopped at 6 months
2027Planned US NDA window

The widely quoted “539% more hair” figure is a relative improvement versus vehicle in one trial, not a 5× density increase on your scalp. We unpack the maths on the studies page.

Start here

Four facts most pages get wrong

It is not on the market for hair yet

Clascoterone 5% scalp solution is investigational. Cosmo Pharmaceuticals plans a US New Drug Application in early 2027. Approval, pricing, and brand launch come after that.

Availability timeline →

Winlevi is not Breezula

Winlevi is a 1% cream approved for acne. The hair trials used a 5% solution. Off-label Winlevi use exists, but it is a different strength and vehicle with no Phase 3 hair data.

Winlevi off-label guide →

Amazon “clascoterone serums” are not the drug

Listings that stamp CLASCOTERONE on a biotin serum are marketing copy. Pharmaceutical clascoterone is a prescription molecule, not an open-shelf cosmetic active.

What is actually proven →

The mechanism is genuinely new

Unlike finasteride (lowers DHT systemically) or minoxidil (vasodilator / potassium-channel effects), clascoterone occupies the androgen receptor in the follicle with negligible systemic absorption in trials.

How it blocks DHT locally →

While you wait

Proven tools you can use today

Pattern hair loss is progressive. Waiting two years for a launch without a plan is how Norwood stages move. The evidence stack that already exists: topical minoxidil 5%, oral finasteride 1 mg where appropriate, ketoconazole shampoo, and a clinician who will photograph your baseline.

See the current stack

Illustrated cross-section of a hair follicle

Disclaimer in one sentence

This site explains research. It does not prescribe.

Talk to a licensed clinician before starting or stopping any hair-loss treatment. Individual results vary. Investigational does not mean available, and available does not mean right for you.

Open the FAQ